ANRO

Alto Neuroscience Inc.

20.87

USD

ANRO Earnings Reports

Positive Surprise Ratio

ANRO beat 5 of 9 last estimates.

56%

Next Report

Date of Next Report

Estimate for Q-- -- (Revenue/ EPS)

Implied change from Q4 25 (Revenue/ EPS)

Implied change from Q-- -- (Revenue/ EPS)

Alto Neuroscience Inc. earnings per share and revenue

On Mar 16, 2026, ANRO reported earnings of -0.57 USD per share (EPS) for Q4 25, missing the estimate of -0.54 USD, resulting in a -7.13% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -6.75% price change (close before vs. close after earnings).

Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Candel Therapeutics, Inc. Common Stock

Report Date

Mar 26, 2026 For Q4 25

Estimate

-$0.25

Actual

-$0.54

Surprise

-115.31%

Acumen Pharmaceuticals, Inc. Common Stock

Report Date

Mar 26, 2026 For Q4 25

Estimate

-$0.46

Actual

-$0.41

Surprise

+11.29%

Rani Therapeutics Holdings, Inc. Class A Common Stock

Report Date

Mar 26, 2026 For Q4 25

Estimate

-$0.06

Actual

-$0.07

Surprise

-2.94%

Spero Therapeutics, Inc. Common Stock

Report Date

Mar 26, 2026 For Q4 25

Estimate

-$0.20

Actual

$0.53

Surprise

+359.80%

Alpha Cognition Inc. Common Stock

Report Date

Mar 26, 2026 For Q4 25

Estimate

-$0.27

Actual

-$0.30

Surprise

-8.93%

Cognition Therapeutics, Inc. Common Stock

Report Date

Mar 26, 2026 For Q4 25

Estimate

-$0.08

Actual

-$0.02

Surprise

+76.47%

Celcuity Inc. Common Stock

Report Date

Mar 25, 2026 For Q4 25

Estimate

-$1.06

Actual

-$0.97

Surprise

+8.72%

Dyadic International, Inc.

Report Date

Mar 25, 2026 For Q4 25

Estimate

-$0.04

Actual

-$0.06

Surprise

-30.72%

Quantum Biopharma Ltd. Class B Subordinate Voting Shares

Report Date

Mar 26, 2026 For Q4 25

Estimate

Actual

-$0.71

Surprise

CollPlant Biotechnologies Ltd Ordinary Shares

Report Date

Mar 26, 2026 For Q4 25

Estimate

-$0.19

Actual

-$0.67

Surprise

-245.72%

FAQ

What were Alto Neuroscience Inc.'s earnings and revenue for the latest quarter Q4 2025?

For Q4 2025, Alto Neuroscience Inc. reported EPS of -$0.57, missing estimates by -7.13%, and revenue of $0.00, 0% as expectations.

How did the market react to Alto Neuroscience Inc.'s Q4 2025 earnings?

The stock price moved down -6.75%, changed from $21.47 before the earnings release to $20.02 the day after.

When is Alto Neuroscience Inc. expected to report next?

The next earning report is scheduled for --.

What are the forecasts for Alto Neuroscience Inc.'s next earnings report?

Based on -- analysts, Alto Neuroscience Inc. is expected to report EPS of -- and revenue of -- for Q-- --.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.